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The demand for chiral organic entities for different industrial purposes has grown exponentially
in the last decades. Concerns about controlling the stereochemistry of the new synthesized
molecules increased significantly when the European Medicines Agency (EMA) and the US Food
and Drug Administration (FDA) launched regulations about the use of chiral molecules not only for
pharmaceutical uses, but also for agrochemicals, cosmetics [1].
For these reasons, different methodologies have been developed in order to obtain access to these
chiral molecules, with the most straightforward way to achieve them being the creation of a stereogenic
center in the molecule. However, this apparently simple task has resulted in being quite challenging
over the years. The main strategies developed and employed so far are asymmetric synthesis by using
a chiral pool or chiral auxiliaries, the resolution of racemates, and so-called enantioselective catalysis
(metal-, organo- and biocatalysis) [2].
In this issue, the majority of the above cited strategies have been gathered together. For example,
Kim, Suh and their co-workers reported the total synthesis of fluvirucin A derivative, belonging to a
family of antibiotic molecules, which contains 4 sterogenic centers by using the asymmetric synthesis
strategy. Thus, starting from an optically active vinylpiperidine as a chiral pool the other centers
were established [3]. The kinetic resolution of racemates is also a commonly employed strategy in
industrial processes. In this special issue, Nakata, Shiina et al. described the kinetic resolution of
racemic 2-hydroxyamides using (R)-benzotetramisole as catalyst with high selectivities. The reaction
pathway and transition states were studied by means of theoretical calculations [4].
Besides these two examples, the majority of articles disclosed in this special issue are based on
enantioselective catalysis. More concretely, there are two articles describing the use of metal-based
chiral catalysts for the obtention of stereogenic centers. In this regard, Fernández-Ibáñez, Maciá
and co-workers describe the use of a chiral complex between 1,1-binaphthalene-2-α-arylmethan-2-ols
(Ar-BINMOLs) and Ti(OiPr)4 acting as a catalyst for the enantioselective addition of organozirconium
reagents, generated in situ, to aldehydes. The corresponding alcohols were obtained in moderate to
good yields and high enantioselectivities [5]. In the other article related to the use of metal catalysts,
Huang and Chang reported the use of an iridium-phosphoramidite chiral complex for the direct
asymmetric reductive amination of O-protected 3-hydroxyacetophenone as a key step for the total
synthesis of (S)-Rivastigmine, an active drug against Alzheimer’s disease. The synthesis of the product
was obtained in only 4 steps with 82% yield and 96% ee [6].
Organocatalysis have emerged as a straightforward and very efficient way to gain access to
chiral organic entities; therefore, the exponential grown that this area has experienced in the last two
decades is not surprising [7]. As matter of fact, in this issue there are four articles on this topic. Thus,
Chinchilla and his group has reported the use of primary amine-salicylamides derived from chiral
trans-cyclohexane-1,2-diamines as a simple and very efficient organocatalyst for the enantioselective
Michael addition of α,α-disubstituted aldehydes to arylated and heteroarylated nitroalkenes obtaining
excellent yields and enantioselectivities for the corresponding adducts. Moreover, theoretical
calculations have been also performed in order to elucidate the reaction mechanism [8]. In another
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work, the group of Huang and Zhang has disclosed the one-pot fluorination and Robinson annulation
sequence for the synthesis of densely substituted cyclohexenones using a cinchona alkaloid amine as
organocatalyst. The products containing two stereocenters were obtained in good yields, diastereo-
and enantioselectivities [9]. Another article dealing with asymmetric organocatalysis has been reported
by our group. In this work a trans-cyclohexanediamine-benzimidazole derivative acts as bifunctional
organocatalyst in the asymmetric electrophilic amination of unprotected 3-substituted oxindoles using
di-tert-butylazodicarboxylate as the aminating agent. The corresponding products bearing a quaternary
stereocenter were obtained in good yields and with good to excellent enantioselectivities [10].
Finally, Herrera and co-workers have disclosed the first organocatalytic asymmetric synthesis of
1-benzamido-1,4-dihydropyridine derivatives through the reaction between preformed hydrazones
and malononitriles using β-isocupreidine as catalyst. This challenging transformation rendered the
corresponding highly functionalized products in good yields and moderate enantioselectivities. [11].
Another strategy has been reported by the Wu and Li group, who combined metal- and
organocatalysis for the tandem Ru-catalyzed oxidative dehydrogenation of tetrahydro-β-carbolines
followed by an aza-Diels–Alder reaction with α,β-unsaturated ketones facilitated by an aminothiourea
organocatalyst. As result, the corresponding indoloquinolizidine-2-ones containing two stereogenic
centers, which are motifs present in different naturally occurring alkaloids, were obtained in moderate
yields, moderate to good diastereoselectivities, and high enantioselectivities [12].
Another important question when working on the creation of stereogenic centers is the
measurement of the optical activity of the new entities. This task is sometimes quite difficult and
time-consuming. Therefore, the development of new and reliable tools for the determination of optical
purity is highly desirable. In this regard, in this issue Lankhorst’s team reported the use of 13C-nuclear
magnetic resonance (NMR) for the determination of the enantiomeric excesses of different mixtures
of mandelonitrile with the aid of the chiral solvating agent (S)-(+)-1-(9-anthryl)-2,2,2-trifluoroethanol
(TFAE). As result of this study, it can be concluded that 13C-NMR can be a straightforward and efficient
methodology for the determination of enantioselectivity in certain molecules [13].
Finally, in this issue a couple of review articles concerning the construction of stereogenic centers
are presented. In one of them, Kawanami et al. present recent developments of a well-known procedure,
the asymmetric borane reduction of carbonyl compounds using oxazaborolidine catalysts [14]. In the
other work, the most recent advances in catalytic (metal-catalyzed and organocatalytic) asymmetric
transformations involving the use of oxaziridines, such as oxidation and amination of prochiral
molecules as well as cycloaddition and deracemization reactions, in order to generate new stereogenic
centers have been comprehensively gathered together by Ren, Yuan and co-workers [15].
In conclusion, it can be said that asymmetric synthesis, in all its aspects, despite being nowadays
a well-established field within organic synthesis is still considered a challenging, constantly growing
and highly interesting area of research. This assertion is reinforced by the fact that there is an
extensive number of articles being published constantly worldwide dedicated to the creation of new
methodologies for the construction of new stereogenic centers, or to the improvement of the efficiency
or performance of previously reported ones. As guest editor of this special issue, I hope that the
selection of articles herein presented can be considered a good reflection of the new findings and the
diversity within this exciting topic.
Funding: This research received no external funding
Acknowledgments: The guest editor would like to thank all the authors that have contributed to this special issue,
and all the reviewers for the evaluation of the submitted articles. Special thanks are also given to the editorial
staff of Molecules, especially Zack Li, as well as the other assistant editors of this journal, who have participated
actively, for their hard work and help in compiling this special issue.
Conflicts of Interest: The author declares no conflicts of interest.
Molecules 2018, 23, 2964 3 of 3
References
1. De Camp, W.H. The FDA perspective on the development of stereoisomers. Chirality 1989, 1, 2–6. [CrossRef]
[PubMed]
2. Jacobsen, E.N.; Pfaltz, A.; Yamamoto, H. Comprehensive Asymmetric Catalysis I-III; Springer-Verlag:
Berlin/Heidelberg, Germany, 2010.
3. Moon, H.; Yoon, H.; Lim, C.; Jang, J.; Yi, J.-J.; Lee, J.K.; Lee, J.; Na, Y.; Son, W.S.; Kim, S.-H.; et al.
Asymmetric Synthesis of (−)-6-Desmethyl-Fluvirucinine A1 via Conformationally-Controlled Diastereoselective
Lactam-Ring Expansions. Molecules 2018, 23, 2351. [CrossRef] [PubMed]
4. Murata, T.; Kawanishi, T.; Sekiguchi, A.; Ishikawa, R.; Ono, K.; Nakata, K.; Shiina, I. Kinetic Resolution of
Racemic 2-Hydroxyamides Using a Diphenylacetyl Component as an Acyl Source and a Chiral Acyl-Transfer
Catalyst. Molecules 2018, 23, 2003. [CrossRef] [PubMed]
5. Solà, R.; Veguillas, M.; González-Soria, M.J.; Carter, N.; Fernández-Ibáñez, M.A.; Maciá, B. Catalytic
Enantioselective Addition of Organozirconium Reagents to Aldehydes. Molecules 2018, 23, 961. [CrossRef]
[PubMed]
6. Gao, G.; Du, S.; Yang, Y.; Lei, X.; Huang, H.; Chang, M. Direct Asymmetric Reductive Amination for the
Synthesis of (S)-Rivastigmine. Molecules 2018, 23, 2207. [CrossRef] [PubMed]
7. List, B. Asymmetric Organocatalysis; Springer-Verlag: Berlin/Heidelberg, Germany, 2010.
8. Martínez-Guillén, J.R.; Flores-Ferrándiz, J.; Gómez, C.; Gómez-Bengoa, E.; Chinchilla, R. Asymmetric
Conjugate Addition of α,α-Disubstituted Aldehydes to Nitroalkenes Organocatalyzed by Chiral
Monosalicylamides from trans-Cyclohexane-1,2-Diamines. Molecules 2018, 23, 141. [CrossRef] [PubMed]
9. Huang, X.; Zhao, W.; Zhang, X.; Liu, M.; Vasconcelos, S.N.S.; Zhang, W. One-pot Fluorination
and Organocatalytic Robinson Annulation for Asymmetric Synthesis of Mono- and Difluorinated
Cyclohexenones. Molecules 2018, 23, 2251. [CrossRef] [PubMed]
10. Benavent, L.; Baeza, A.; Freckleton, M. Chiral 2-Aminobenzimidazole as Bifunctional Catalyst in the
Asymmetric Electrophilic Amination of Unprotected 3-Substituted Oxindoles. Molecules 2018, 23, 1374.
[CrossRef] [PubMed]
11. Auria-Luna, F.; Marqués-López, E.; Herrera, R.P. First Organocatalytic Asymmetric Synthesis of
1-Benzamido-1,4-Dihydropyridine Derivatives. Molecules 2018, 23, 2692. [CrossRef] [PubMed]
12. Wu, X.; Zhao, S.-B.; Zheng, L.-L.; Li, Y.-G. Oxidative Asymmetric Formal Aza-Diels–Alder Reactions of
Tetrahydro-β-carboline with Enones in the Synthesis of Indoloquinolizidine-2-ones. Molecules 2018, 23, 2228.
[CrossRef] [PubMed]
13. Lankhorst, P.P.; van Rijn, J.H.J.; Duchateau, A.L.L. One-Dimensional 13C-NMR Is a Simple and Highly
Quantitative Method for Enantiodiscrimination. Molecules 2018, 23, 1785. [CrossRef] [PubMed]
14. Kawanami, Y.; Yanagita, R.C. Practical Enantioselective Reduction of Ketones Using Oxazaborolidine
Catalysts Generated In Situ from Chiral Lactam Alcohols. Molecules 2018, 23, 2408. [CrossRef] [PubMed]
15. Ren, Q.; Yang, W.; Lan, Y.; Qin, X.; He, Y.; Yuan, L. Recent Advances in the Catalytic Asymmetric Reactions
of Oxaziridines. Molecules 2018, 23, 2656. [CrossRef] [PubMed]
© 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
